Tonix Pharmaceuticals (TNXP) Q3 2024 Earnings

19AugConfirmed
Q2 2023
Q3 2023
Q2 2024
Q3 2024
-19.28
-13.35
-7.42
-1.49

Details

Expected EPS
-3.273333
Actual EPS
-19.28
Surprise EPS
-16.01
Surprise Percent
+489%

Description

Tonix Pharmaceuticals (TNXP) has reported earnings of -19.28 per share for Q3 2024.

0 Comments

Share your thoughts